# Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

> **NCT04832607** · PHASE3 · RECRUITING · sponsor: **Tobias Feuchtinger** · enrollment: 149 (estimated)

## Conditions studied

- AdV Infection
- EBV Infection
- CMV Infection
- Stem Cell Transplant Complications

## Interventions

- **OTHER:** Multivirus (CMV, EBV, AdV)-specific T cells

## Key facts

- **NCT ID:** NCT04832607
- **Lead sponsor:** Tobias Feuchtinger
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-27
- **Primary completion:** 2028-03
- **Final completion:** 2028-09
- **Target enrollment:** 149 (ESTIMATED)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04832607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04832607, "Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04832607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*